Position in FATE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,360,515
+$6,758,693 QoQ
Shares Held
3,837,229
+27.8% QoQ
Ownership
3.20%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 156 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. FATE ranks #52 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in FATE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,360,515 | 3,837,229 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $3,601,822 | 3,001,521 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,138,762 | 1,162,005 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,425,580 | 1,131,414 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $947,779 | 846,233 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $462,167 | 585,025 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $243,542 | 147,602 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $84,293 | 24,084 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $53,988 | 16,460 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $162,199 | 22,098 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $879,116 | 235,058 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $705,771 | 332,911 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $1,546,974 | 271,399 | Shares | Defined | 2023-05-15 | |
| 2022-03-31 | $598,531 | 15,438 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,569,881 | 26,831 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,141,543 | 36,132 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,308,781 | 38,124 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,790,685 | 33,847 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,211,829 | 35,322 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,619,024 | 40,506 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,697,830 | 49,485 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $1,165,558 | 52,479 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||